1995
DOI: 10.1136/bmj.311.7016.1347
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in prescribing by general practitioner fundholders: an observational study

Abstract: Objectives-To compare prescribing in general practices before and after they become fundholders to assess whether this affected prescribing patterns.Design-Analysis of prescribing data (PACT) for one year before and one year after practices become first, second, or third wave fundholders and comparison with practices that were not fundholders during any part ofthe study.Main outcome measures-Prescribing costs (net ingredient cost per prescribing unit), prescribing volume (items per 1000 prescribing units), net… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

1999
1999
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(39 citation statements)
references
References 10 publications
(9 reference statements)
0
39
0
Order By: Relevance
“…In accordance with research into changes made by general medical practitioners, [24][25][26] this study assessed change within general dental practice based upon self reports. Such an approach has some limitations.…”
Section: Discussionmentioning
confidence: 99%
“…In accordance with research into changes made by general medical practitioners, [24][25][26] this study assessed change within general dental practice based upon self reports. Such an approach has some limitations.…”
Section: Discussionmentioning
confidence: 99%
“…It is, however, difficult to argue conclusively that overall efficiencies in prescribing have resulted, as many practices strategically delayed entry into the fundholding scheme to maximise their prescribing budgets (Wilson, Buchnan & Walley 1995).…”
Section: Flow-on Costsmentioning
confidence: 99%
“…Budget-holding introduces incentives to encourage cost-effective care through making GPs, as purchasers, responsible for the wider flow-on costs of any care prescribed and providing an effective cap on the level of overall public expenditure (Malcolm & Powell 1996). For pharmaceuticals, this means that GPs will more carefully consider which drug is most appropriate and in which circumstance and, thus, prescribing of the most expensive 'flavour of the month' drug is unlikely to be sustained (Wilson, Buchnan & Walley 1995).…”
Section: Flow-on Costsmentioning
confidence: 99%
“…183,184 Evaluations of the impact of fundholding on prescribing have also used PPA data. [185][186][187][188] The Health Survey for England (HSE) differs from other databases discussed here in being a regular survey of some 20,000 individuals by household. It has been used to show the proportions of people with raised cholesterol who are taking lipidlowering medication.…”
Section: Use In Ht Assessmentmentioning
confidence: 99%